...
首页> 外文期刊>Somatic Cell and Molecular Genetics >Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
【24h】

Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.

机译:突变亨廷顿蛋白形成的淀粉样蛋白:正常聚谷氨酰胺蛋白的阈值,进行性和募集。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Huntington's disease (HD) is caused by an expanded CAG trinucleotide repeat encoding a tract of consecutive glutamines near the amino terminus of huntingtin, a large protein of unknown function. It has been proposed that the expanded polyglutamine stretch confers a new property on huntingtin and thereby causes cell and region-specific neurodegeneration. Genotype-phenotype correlations predict that this novel property appears above a threshold length (approximately 38 glutamines), becomes progressively more evident with increasing polyglutamine length, is completely dominant over normal huntingtin and is not appreciably worsened by a double genetic dose in HD homozygotes. Recently, an amino terminal fragment of mutant huntingtin has been found to form self-initiated fibrillar aggregates in vitro. We have tested the capacity for aggregation to assess whether this property matches the criteria expected for a fundamental role in HD pathogenesis. We find that that in vitro aggregation displays a threshold and progressivity for polyglutamine length remarkably similar to the HD disease process. Moreover, the mutant huntingtin amino terminus is capable of recruiting into aggregates normal glutamine tract proteins, such as the amino terminal segments of both normal huntingtin and of TATA-binding protein (TBP). Our examination of in vivo aggregates from HD post-mortem brains indicates that they contain an amino terminal segment of huntingtin of between 179 and 595 residues. They also contain non-huntingtin protein, as evidenced by immunostaining for TBP. Interestingly, like the in vitro aggregates, aggregates from HD brain display Congo red staining with green birefringence characteristic of amyloid. Our data support the view that the expanded polyglutamine segment confers on huntingtin a new property that plays a determining role in HD pathogenesis and could be a target for treatment. Moreover, the new property might have its toxic consequences by interaction with one or more normal polyglutamine-containing proteins essential for the survival of target neurons.
机译:亨廷顿舞蹈病(HD)是由扩大的CAG三核苷酸重复序列引起的,该重复序列编码在亨廷顿蛋白(一种未知功能的大蛋白)的氨基末端附近的连续谷氨酰胺片段。已经提出,扩展的聚谷氨酰胺伸展带赋予亨廷顿蛋白新的特性,从而引起细胞和区域特异性神经变性。基因型与表型的相关性预测这种新特性会出现在阈值长度以上(约38个谷氨酰胺),随着聚谷氨酰胺长度的增加而逐渐变得更加明显,在正常亨廷顿蛋白中占绝对优势,并且不会因HD纯合子的双重遗传剂量而明显恶化。最近,已发现突变亨廷顿蛋白的氨基末端片段在体外形成自引发的原纤维聚集体。我们已经测试了聚集的能力,以评估该特性是否符合在HD发病机理中起基本作用的预期标准。我们发现,体外聚集显示的阈值和聚谷氨酰胺长度的进展非常类似于高清疾病过程。此外,突变的亨廷顿蛋白氨基末端能够募集正常谷氨酰胺束蛋白,例如正常亨廷顿蛋白和TATA结合蛋白(TBP)的氨基末端片段的聚集体。我们对高清验尸大脑中体内聚集物的检查表明,它们含有亨廷顿蛋白的氨基末端片段,介于179至595个残基之间。它们还含有非亨廷顿蛋白,如TBP免疫染色所证明。有趣的是,像体外聚集体一样,高清大脑聚集体显示出刚果红染色,具有淀粉样蛋白的绿色双折射特征。我们的数据支持这样的观点,即扩展的聚谷氨酰胺片段赋予亨廷顿一种新特性,该新特性在高清发病机理中起决定性作用,并且可能成为治疗的靶标。此外,新特性可能会与一种或多种对目标神经元的生存至关重要的含正常聚谷氨酰胺的蛋白质相互作用而产生毒性后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号